Comparison of Latanoprost and Timolol in Pediatric Glaucoma: A Phase 3, 12-Week, Randomized, Double-Masked Multicenter Study

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F11%3A7500" target="_blank" >RIV/00064203:_____/11:7500 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11130/11:7500

Result on the web

<a href="http://dx.doi.org/10.1016/j.ophtha.2011.03.010" target="_blank" >http://dx.doi.org/10.1016/j.ophtha.2011.03.010</a>

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Comparison of Latanoprost and Timolol in Pediatric Glaucoma: A Phase 3, 12-Week, Randomized, Double-Masked Multicenter Study

Original language description

Randomised, Double-Masked, Multicenter, 12-Week Study fo compare the efficacy and safety of latanoprost versus timolol in pediatric patients with glaucoma. Latanoprost 0.005 % was not inferior to timolol 0.5 % (0.25 % in children aged less than 3 years)and produced clinically relevant intraocular pressure reduction across pediatric patients with primary congenital glaucoma or secondary glaucoma. Both latanoprost and timolol had favorable safery profiles over the duration of the study.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FF - ENT (ie. ear, nose, throat), ophthalmology, dentistry

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2011

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Ophthalmology

ISSN

0161-6420

e-ISSN

—

Volume of the periodical

118

Issue of the periodical within the volume

10

Country of publishing house

US - UNITED STATES

Number of pages

8

Pages from-to

2014-2021

UT code for WoS article

000296066900020

EID of the result in the Scopus database

—